Azithromycin Pulses for the Treatment of Epidermal Growth Factor Receptor Inhibitor-Related Papulopustular Eruption: An Effective and Convenient Alternative to Tetracyclines

Background: Papulopustular eruption (PPE) is the most common cutaneous side effect of epidermal growth factor receptor inhibitors (EGFRIs). Objective: To document the efficacy and safety of pulsed azithromycin doses in the treatment of EGFRI-related PPE. Methods: A retrospective analysis of patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dermatology (Basel) 2012-01, Vol.224 (4), p.315-319
Hauptverfasser:	Nikolaou, Vasiliki, Strimpakos, Alexios S., Stratigos, Alexander, Katsambas, Andreas, Antoniou, Christina, Syrigos, Kostas N.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anti-Bacterial Agents - therapeutic use Antibiotics Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Humanized Azithromycin - therapeutic use Cetuximab Drug Eruptions - drug therapy Drug Eruptions - etiology Epidermal growth factor Erlotinib Hydrochloride Exanthema - chemically induced Exanthema - drug therapy Female Humans Inhibitor drugs Male Middle Aged Neoplasms - drug therapy Original Paper Pulse Therapy, Drug Quinazolines - adverse effects Receptor, Epidermal Growth Factor - antagonists & inhibitors Retrospective Studies Side effects Skin diseases Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!